Structural and dynamics analysis of pyruvate kinase from erythrocytes: implications in pathology by Jordà, Luis & Gelpí, Josep Lluís
Structural and Dynamics Analysis of Pyruvate Kinase 
from Erythrocytes: Implications in Pathology 
Luis Jordà#1, Josep Lluís Gelpí#*2 
#Barcelona Supercomputing Center (BSC) 
*University of Barcelona (UB), Department of Biochemistry and Molecular Biology, 08028-Barcelona, Spain 
1luis.jorda@bsc.es, 2gelpi@ub.edu 
Keywords — Pathogenicity prediction, pathogenic variant, protein  
  dynamics, molecular dynamics, pyruvate kinase.
EXTENDED ABSTRACT 
Our current study revolves around the dynamic 
characterization of the human erythrocyte pyruvate kinase (R-
PYK). The deficiency of this protein is a common cause of 
nonspherocytic hemolytic anemia, a rare, autosomal recessive 
disease. We plan to perform a comprehensive set of molecular 
dynamics simulations of both the wildtype (WT) and mutant 
variants of R-PYK in different conditions, in order to explore 
the dynamic behavior of the enzyme, describe the function 
and allosteric mechanism in terms of its dynamics fingerprint 
and identify altered dynamic behavior of the known 
pathogenic variants of the enzyme. 
A. Introduction 
Amino acid substitutions are implicated in a wide range of 
human diseases, as they are often the direct cause for a protein 
to partially or totally lose its function [1]. With the rise of 
high-throughput sequencing techniques, a very frequent 
clinical procedure consists in analyzing the genotype of 
patients who suffer from a disease to confirm or deny the 
presence of a mutation in the involved genes. Distinguishing 
such mutations from polymorphisms without significant effect 
on human health is a necessary step in understanding the 
etiology of mutation-related diseases [1]. Amino acidic 
replacements can affect to a different extent the stability, 
catalytic efficiency and regulatory properties of proteins. 
However, in the majority of the cases there is no apparent 
relationship between the nature and location of the replaced 
amino acid and the type of molecular perturbation [2]. This 
fact makes predicting the functional effects of missense 
variants in proteins a challenging task.  
This field of study has been addressed in the recent years, 
and a considerable amount of bioinformatics tools to tackle 
the problem have been developed. However, while most state-
of-the-art pathogenicity predictors rely on sequence-based 
features of proteins to identify damaging variants [3], 
structural and dynamic features have been largely neglected, 
mainly due to the difficulties and computational cost of their 
obtainment. Although molecular dynamics (MD) simulations 
have been traditionally employed to study the impact of 
mutations on the dynamic behavior of proteins, these studies 
are generally based on qualitative terms, and we still lack 
techniques to better quantify these dynamic effects. Our 
research line aims to improve pathogenicity prediction 
algorithms by establishing a protocol or guidelines that 
consider the role of dynamics features in the functional 
behavior of protein variants. 
B. Use case 
To this end, we are studying the particular case of the 
human erythrocyte pyruvate kinase (R-PYK). This protein is 
one of the most widely studied enzymes throughout the 
history of biochemistry, due to its major role in the regulation 
of glycolysis. It catalyzes the irreversible conversion of 
phosphoenolpyruvate (PEP) to pyruvate, generating an ATP 
molecule in the process. The enzyme needs cofactors (K+ and 
Mg2+) for proper catalytic activity, and is allosterically 
regulated by fructose-1,6-biphosphate (FBP), an activator of 
its catalytic efficiency. Pyruvate kinase has a highly conserved 
architecture throughout evolution (Fig. 1) [2].  
 
 
 
 
 
Fig. 1  Tertiary and quaternary structure of R-PYK. The different domains of 
the protein: N-terminal, A, B and C are colored green, red, blue and yellow 
respectively. A) View of a monomer of R-PYK and bound cofactors, 
substrate and allosteric activator. B) View of the tetramer of R-PYK. The two 
symmetry axes are shown with a dashed line. Only one subunit is colored as 
indicated above (the rest are colored pale cyan). Images generated with the 
software VMD. 
Hundreds of missense mutations in various sites of R-PYK 
have been clinically associated to a disease called hereditary 
nonspherocytic hemolytic anemia (5 cases per 10,000 
individuals in Europe) [4]. The main aim is to go deeper into 
the coupling between structure and functions of this protein, 
as well as to provide information about its dynamic properties 
for both the WT form and some of its mutant variants of 
known pathological consequences. 
C. Preliminary results 
So far, we have started to characterize the main motions 
occurring in the WT enzyme, as well as some potential 
alterations of these patterns in the mutated forms of the 
protein. These preliminary descriptions are the result of the 
analysis of 100 ns long MD simulations run on both the WT 
(5 replicas) and 62 relevant pathogenic and neutral variants 
extracted from literature and clinical sources. The amino 
acidic substitutions affect various regions of the protein, such 
as the active and allosteric sites, subunit interfaces and 
hydrophobic cores. 
A thorough examination of the generated trajectories 
allowed us to understand the main concerted motions that 
govern the dynamics of the enzyme, in accordance with the 
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previously described features of its biological function and 
mechanism. 
D. Future development 
In the current stage of the project we are expanding the 
amount of MD simulations to cover a more comprehensive 
representation of the biologically meaningful conditions of the 
enzyme. Until now, the simulations consisted of the 
apoenzyme (only protein residues), therefore, we will 
establish several additional conditions of the enzyme bound to 
its cofactors (K+ and Mg2+), substrates (PEP and ADP) and the 
allosteric activator (FBP), in different combinations, and both 
for the WT and the mutant variants. To achieve this, we will 
use quantum mechanics (QM) approaches to model the bound 
ligands, prior to the MD simulations. The intended production 
MD simulation length of each variant will be of 200 ns. 
Through the analysis of all the generated data, we aim to 
establish a model to better explain the potential dynamic 
and/or structural alterations of each amino acid replacement in 
contrast with the WT behavior. 
Later stages of the project will include, at least, generating 
a set of metrics (structural and derived from essential 
dynamics analyses) with discriminative power, training an R-
PYK specific machine learning model to predict pathogenicity, 
validating it with more R-PYK variants and testing it with 
more proteins of similar features. 
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